Loading clinical trials...
Loading clinical trials...
The investigator conduct a phase II multi-center, open-label trial to evaluate efficacy and safety of dalpiciclib with endocrine therapy as adjuvant treatment in patients with medium /high risk hormon...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
NCT05774951 · Breast Cancer, Early Breast Cancer
NCT07379918 · Breast Cancer (Early Breast Cancer), Breast Cancer Survivors, and more
NCT06797531 · HR+/HER2- Early Breast Cancer
NCT07331506 · Breast Cancer Detection, Breast Cancer Early Stage Breast Cancer (Stage 1-3), and more
NCT07007169 · Early Breast Cancer
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions